Pricing overhaul

Dispensing fees, pricing discretion and pharmacy layout in the King Review firing line Pharmacies should have no discretion to either raise or lower prices for PBS-listed medicines beyond the co-payment set by the government or the dispensed price, the Review of Pharmacy Remuneration and Regulation has recommended. The interim report of the Review of Pharmacy

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous King Review option treats pharmacy like 'utility company'
Next New PSA National President to tackle recognition, remuneration